Literature DB >> 17956289

Defining a role for platelets in allergic inflammation.

S C Pitchford1.   

Abstract

There is now considerable evidence suggesting a role for platelets as inflammatory cells. These actions are distinct from their classically known actions performed during thrombosis and haemostasis, and include the expression of adhesion molecules and contact-dependent activation of leucocytes, the release of a plethora of inflammatory mediators, activation in cells of the adaptive immune response and the ability to migrate and undergo chemotaxis. Chronic asthma is a disease characterized by a mixed inflammatory cell pulmonary infiltrate, AHR (airways hyper-responsiveness) and tissue remodelling. Clinical data from patients suffering from asthma, allergic rhinitis and allergic dermatitis reveal changes in platelet behaviour and function during or after allergen exposure. Furthermore, mouse models of allergic inflammation demonstrate a role for intact platelets in eosinophil and lymphocyte recruitment to the lungs, a mechanism that is P-selectin (platelet selectin)-dependent. Models of chronic inflammation also reveal the participation of platelets in tissue remodelling events whereby platelet depletion was found to be more effective in suppressing airway remodelling processes than the administration of a glucocorticosteroid. This process of destruction and repair to the architecture of airway tissue is therefore perhaps enhanced by platelet activation. Recent evidence demonstrates that platelets can undergo chemotaxis and indicates an ability to migrate through inflamed tissue, where they localize to specific tissue sites. Indeed, platelets have been shown to become activated and recruited to various body compartments in direct response to allergen via IgE and this is suggestive of a link between the innate and adaptive immune responses. Thus these actions may lead to pathophysiological events that alter disease progression, since platelet depletion suppresses AHR in allergic rabbits. Further investigations into the role of platelets in inflammation may be beneficial in the search for future therapeutic targets in the treatment of asthma and allergy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956289     DOI: 10.1042/BST0351104

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.

Authors:  Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  Am J Respir Crit Care Med       Date:  2012-01-06       Impact factor: 21.405

Review 2.  In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.

Authors:  Abdelbaset A Elzagallaai; Michael J Rieder
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

3.  Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: a multicentric case-control study.

Authors:  Elena Mazzotta; Adriana Agostinone; Raffaella Rosso; Antonio Di Biagio; Giuseppe Vittorio De Socio; Anna Cappelletti; Raffaele Zicolella; Ennio Polilli; Paolo Bonfanti; Luigi Di Matteo; Lamberto Manzoli; Giustino Parruti
Journal:  J Bone Miner Metab       Date:  2011-01-22       Impact factor: 2.626

4.  Airway platelet activation is associated with airway eosinophilic inflammation in asthma.

Authors:  Angela S Benton; Nikila Kumar; Jennifer Lerner; Andrew A Wiles; Matthew Foerster; Stephen J Teach; Robert J Freishtat
Journal:  J Investig Med       Date:  2010-12       Impact factor: 2.895

Review 5.  Platelets in inflammation: regulation of leukocyte activities and vascular repair.

Authors:  Angèle Gros; Véronique Ollivier; Benoît Ho-Tin-Noé
Journal:  Front Immunol       Date:  2015-01-06       Impact factor: 7.561

Review 6.  The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis.

Authors:  Galateja Jordakieva; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2018-08-15       Impact factor: 4.084

7.  Can mean platelet volume be used as a biomarker for asthma?

Authors:  Hikmet Tekin Nacaroglu; Rana Isguder; Semiha Erdem Bahceci; Gökhan Ceylan; Huseyin Anil Korkmaz; Sait Karaman; Canan Sule Unsal Karkıner; Demet Can
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.